AI Article Synopsis

  • The study aimed to evaluate the cost-effectiveness of various treatments for cervical intraepithelial neoplasia (CIN) in women in England.
  • A decision-analytic model simulated the outcomes for 1,000 women receiving local treatment for CIN over a 10-year follow-up, considering surgical complications and related costs to the NHS.
  • Results indicated that large loop excision of the transformation zone (LLETZ) was the most cost-effective treatment for both younger and older women, with laser conisation becoming more viable for older women if costs were above £31,500 per recurrence averted.

Article Abstract

Objective: To compare the cost-effectiveness of different treatments for cervical intraepithelial neoplasia (CIN).

Design: A cost-effectiveness analysis based on data available in the literature and expert opinion.

Setting: England.

Population: Women treated for CIN.

Methods: We developed a decision-analytic model to simulate the clinical course of 1000 women who received local treatment for CIN and were followed up for 10 years after treatment. In the model we considered surgical complications as well as oncological and reproductive outcomes over the 10-year period. The costs calculated were those incurred by the National Health Service (NHS) of England.

Main Outcome Measures: Cost per one CIN2+ recurrence averted (oncological outcome); cost per one preterm birth averted (reproductive outcome); overall cost per one adverse oncological or reproductive outcome averted.

Results: For young women of reproductive age, large loop excision of the transformation zone (LLETZ) was the most cost-effective treatment overall at all willingness-to-pay thresholds. For postmenopausal women, LLETZ remained the most cost-effective treatment up to a threshold of £31,500, but laser conisation became the most cost-effective treatment above that threshold.

Conclusions: LLETZ is the most cost-effective treatment for both younger and older women. However, for older women, more radical excision with laser conisation could also be considered if the NHS is willing to spend more than £31,500 to avert one CIN2+ recurrence.

Download full-text PDF

Source
http://dx.doi.org/10.1111/1471-0528.17829DOI Listing

Publication Analysis

Top Keywords

cost-effective treatment
16
cervical intraepithelial
8
intraepithelial neoplasia
8
cost-effectiveness analysis
8
oncological reproductive
8
cin2+ recurrence
8
outcome cost
8
reproductive outcome
8
lletz cost-effective
8
laser conisation
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!